Status:
UNKNOWN
Immunogenicity of COVID-19 Vaccination in PLWH
Lead Sponsor:
CIHR Canadian HIV Trials Network
Collaborating Sponsors:
McGill University Health Centre/Research Institute of the McGill University Health Centre
The Ottawa Hospital (TOH)
Conditions:
HIV Infections
Eligibility:
All Genders
16+ years
Brief Summary
Various facts support the study of COVID-19 vaccine immunogenicity in People Living With HIV (PLWH) at this time: (1) Many PLWH in Canada will be eligible to receive COVID-19 vaccination as they are i...
Eligibility Criteria
Inclusion
- Age \>/=16 years (Sites may choose to only enrol adults based on their provincial age of majority)
- HIV positive for HIV group; For HIV negative group, individuals should be immunocompetent and generally in good health (i.e. participants should not have a condition associated with immunodeficiency nor be receiving immunosuppressant medication)
- Receiving at least 1 dose of COVID-19 vaccine, or have received 1 or 2 doses of a COVID-19 vaccine
- Able to provide signed, informed consent
- Able to attend study visits
Exclusion
- Signs or symptoms of active COVID-19 infection
- For HIV-uninfected persons: immune-compromising conditions or on medication which suppresses the immune response
Key Trial Info
Start Date :
June 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04894448
Start Date
June 10 2021
End Date
July 31 2023
Last Update
October 15 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital (TOH)
Ottawa, Ontario, Canada
2
University Health Network (UHN)
Toronto, Ontario, Canada
3
Chronic Viral Illness Service (CVIS) McGill University Health Centre (MUHC)
Montreal, Quebec, Canada